BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33606120)

  • 1. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old.
    Blázquez-Gamero D; Epalza C; Cadenas JAA; Gero LC; Calvo C; Rodríguez-Molino P; Méndez M; Santos MDM; Fumadó V; Guzmán MF; Soriano-Arandes A; Jiménez AB; Penin M; Cobo-Vazquez E; Pareja M; Lobato Z; Serna M; Delgado R; Moraleda C; Tagarro A
    Eur J Pediatr; 2021 Jul; 180(7):2099-2106. PubMed ID: 33606120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial coinfection in young febrile infants with SARS-CoV-2 infection.
    Hernández-Bou S; Trenchs V; Diego P; Seguí A; Luaces C
    Eur J Pediatr; 2024 Jan; 183(1):281-288. PubMed ID: 37872349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Serious Bacterial Infection in Febrile Infants Less Than 60 Days Old.
    Guernsey D; Pfeffer M; Kimpo J; Vazquez H; Zerzan J
    West J Emerg Med; 2022 Aug; 23(5):754-759. PubMed ID: 36205666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of serious bacterial infection in febrile infants under 3 months of age and diagnostic management in Mayotte.
    Haji S; Ouchinsky Z; Djoumoi B; Benoit-Cattin T; Chamouine A
    Arch Pediatr; 2021 Oct; 28(7):553-558. PubMed ID: 34400055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology, Treatment, and Outcome of Children Aged 3 to 36 Months With Fever Without a Source at a Community Hospital in Southern Thailand.
    Phasuk N; Nurak A
    J Prim Care Community Health; 2020; 11():2150132720915404. PubMed ID: 32340537
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 in Infants Younger Than 90 Days Presenting to the Pediatric Emergency Department: Clinical Characteristics and Risk of Serious Bacterial Infection.
    Benenson-Weinberg T; Gross I; Bamberger Z; Guzner N; Wolf D; Gordon O; Nama A; Hashavya S
    Pediatr Emerg Care; 2023 Dec; 39(12):929-933. PubMed ID: 37039445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterovirus neurological disease and bacterial coinfection in very young infants with fever.
    Calvo C; Gallardo P; Torija P; Bellón S; Méndez-Echeverría A; Del Rosal T; Baquero-Artigao F; Sainz T; Romero M; Cabrerizo M
    J Clin Virol; 2016 Dec; 85():37-39. PubMed ID: 27833059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Serious Bacterial Infections in Young Febrile Infants With COVID-19.
    Payson A; Etinger V; Napky P; Montarroyos S; Ruiz-Castaneda A; Mestre M
    Pediatr Emerg Care; 2021 Apr; 37(4):232-236. PubMed ID: 33780408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Among Infants <90 Days of Age Admitted for Serious Bacterial Infection Evaluation.
    Paret M; Lalani K; Hedari C; Jaffer A; Narayanan N; Noor A; Lighter J; Madan RP; Shust GF; Ratner AJ; Raabe VN
    Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34193619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days With SARS-CoV-2.
    Aronson PL; Louie JP; Kerns E; Jennings B; Magee S; Wang ME; Gupta N; Kovaleski C; McDaniel LM; McDaniel CE;
    JAMA Netw Open; 2023 May; 6(5):e2313354. PubMed ID: 37171815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viremia as a predictor of absence of serious bacterial infection in children with fever without source.
    Galetto-Lacour A; Cordey S; Papis S; Mardegan C; Luterbacher F; Combescure C; Lacroix L; Gervaix A; Kaiser L; Posfay-Barbe KM; L'Huillier AG
    Eur J Pediatr; 2023 Feb; 182(2):941-947. PubMed ID: 36399200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patients presenting with febrile seizures in an Iranian referral hospital: emphasis on the frequency of meningitis and co-infections.
    Soti Khiabani M; Mohammadi MS; Ashrafi MR; Haider SB; Haider SI; Mahmoudi S; Mamishi S
    BMC Pediatr; 2023 Jun; 23(1):316. PubMed ID: 37349740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series.
    More K; Aiyer S; Goti A; Parikh M; Sheikh S; Patel G; Kallem V; Soni R; Kumar P
    Eur J Pediatr; 2022 May; 181(5):1883-1898. PubMed ID: 35031848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the systemic immune-inflammation index to predict serious bacterial infections in infants with fever without a source.
    Güngör A; Göktuğ A; Yaradılmış RM; Güneylioğlu MM; Öztürk B; Bodur İ; Karacan CD; Tuygun N
    Postgrad Med; 2022 Sep; 134(7):698-702. PubMed ID: 35705191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Infection in Well-Appearing 30- to 90-Day-Old Infants with Fever without a Source.
    Güngör A; Bodur İ; Göktuğ A; Güneylioğlu MM; Öztürk B; Yaradılmış RM; Yalçınkaya R; Karacan CD; Tuygun N
    J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35666180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study.
    Zimmermann P; Uka A; Buettcher M; Fougère Y; Plebani M; Relly C; Schmid H; Ritz N;
    Swiss Med Wkly; 2022 May; 152():w30185. PubMed ID: 35748304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to Neonates and Young Infants with Fever without a Source Who Are at Risk for Severe Bacterial Infection.
    Esposito S; Rinaldi VE; Argentiero A; Farinelli E; Cofini M; D'Alonzo R; Mencacci A; Principi N
    Mediators Inflamm; 2018; 2018():4869329. PubMed ID: 30581369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Disease in Presenting to the Pediatric Emergency Department: A Multicenter Study of 8886 Cases.
    Duman M; Şık N; Tekşam Ö; Akça H; Kurt F; Çağlar AA; Yıldız LA; Taşar MA; Fidancı İ; Yayla BCC; Yılmaz D; Güngör E; Demir Ş; Çokuğraş H; Cebeci SO; Önal P; Saz EU; Yurtseven A; Uysalol M; Yıldız R; Gümüş S; Bal A; Bayturan SŞ; Zengin N; Atik S; Çiftdoğan DY; Berksoy E; Çiçek A; Şahin S; Kızıl MC; Kara Y; Apa H; Ulusoy E; Kara AA; Yesil E; Erdem M; Turan C; Arslanoglu S; Duyu M; Besli GE; Arslan G; Oflu AT; Çeleğen M; Buldu E; Pişkin İE; Kardeş H; Yılmaz HL; Yıldızdaş D; Gökulu G; Çay P; Özer U; Güleryüz OD; Çolak Ö; Güneysu ST
    Am J Emerg Med; 2022 Sep; 59():133-140. PubMed ID: 35849960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections.
    Levine DA; Platt SL; Dayan PS; Macias CG; Zorc JJ; Krief W; Schor J; Bank D; Fefferman N; Shaw KN; Kuppermann N;
    Pediatrics; 2004 Jun; 113(6):1728-34. PubMed ID: 15173498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.